Is KRYS a good stock to buy? We came across a bullish thesis on Krystal Biotech, Inc. on Investment Management Academy’s Substack. In this article, we will summarize the bulls’ thesis on KRYS. Krystal Biotech, Inc.'s share was trading at $310.30 as of May 28th. KRYS’s trailing and forward P/E were 41.55 and 45.45 respectively according to Yahoo Finance.
[caption id="attachment_575381" align="aligncenter" width="750"]Krystal Biotech (KRYS) is a gene therapy company focused on rare diseases built around its proprietary HSV-1 vector...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.